BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31856917)

  • 1. Evaluation of antibody responses to the early transcribed membrane protein family in Plasmodium vivax.
    Lee SK; Han JH; Park JH; Ha KS; Park WS; Hong SH; Na S; Cheng Y; Han ET
    Parasit Vectors; 2019 Dec; 12(1):594. PubMed ID: 31856917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of Pv50, a novel Plasmodium vivax merozoite surface protein.
    Cheng Y; Wang B; Lu F; Ahmed MA; Han JH; Na SH; Ha KS; Park WS; Hong SH; Han ET
    Parasit Vectors; 2019 Apr; 12(1):176. PubMed ID: 30999945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenicity and immunogenicity of PvRALP1, a novel Plasmodium vivax rhoptry neck protein.
    Cheng Y; Li J; Ito D; Kong DH; Ha KS; Lu F; Wang B; Sattabongkot J; Lim CS; Tsuboi T; Han ET
    Malar J; 2015 Apr; 14():186. PubMed ID: 25925592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeast.
    Vicentin EC; Françoso KS; Rocha MV; Iourtov D; Dos Santos FL; Kubrusly FS; Sakauchi MA; Raw I; Nosten F; Rénia L; Rodrigues MM; Russell B; Soares IS
    Infect Immun; 2014 Mar; 82(3):1296-307. PubMed ID: 24379279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium vivax apical membrane antigen-1: comparative recognition of different domains by antibodies induced during natural human infection.
    Múfalo BC; Gentil F; Bargieri DY; Costa FT; Rodrigues MM; Soares IS
    Microbes Infect; 2008 Oct; 10(12-13):1266-73. PubMed ID: 18692152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
    Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
    Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Naturally Acquired Antibody Responses to Two Variant Forms of Plasmodium vivax Apical Membrane Antigen-1 in Individuals Living in Areas of Low and Unstable Malaria Transmission of Iran.
    Salavatifar M; Zakeri S; Abouie Mehrizi A; Mirkhazemi S; Dinparast Djadid N
    Arch Iran Med; 2015 Dec; 18(12):834-43. PubMed ID: 26621016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
    Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
    Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological, immunological and functional properties of two novel multi-variant chimeric recombinant proteins of CSP antigens for vaccine development against Plasmodium vivax infection.
    Shabani SH; Zakeri S; Salmanian AH; Amani J; Mehrizi AA; Snounou G; Nosten F; Andolina C; Mourtazavi Y; Djadid ND
    Mol Immunol; 2017 Oct; 90():158-171. PubMed ID: 28800475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and Kinetics of Complement-Fixing Antibodies Against Plasmodium vivax Merozoite Surface Protein 3α and Relationship With Immunoglobulin G Subclasses and Immunoglobulin M.
    Oyong DA; Wilson DW; Barber BE; William T; Jiang J; Galinski MR; Fowkes FJI; Grigg MJ; Beeson JG; Anstey NM; Boyle MJ
    J Infect Dis; 2019 Nov; 220(12):1950-1961. PubMed ID: 31419296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Pv92, a Novel Merozoite Surface Protein of Plasmodium vivax.
    Lee SK; Wang B; Han JH; Nyunt MH; Muh F; Chootong P; Ha KS; Park WS; Hong SH; Park JH; Han ET
    Korean J Parasitol; 2016 Aug; 54(4):385-91. PubMed ID: 27658588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli.
    Oliveira-Ferreira J; Vargas-Serrato E; Barnwell JW; Moreno A; Galinski MR
    Vaccine; 2004 May; 22(15-16):2023-30. PubMed ID: 15121316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax.
    Gupta S; Singh S; Popovici J; Roesch C; Shakri AR; Guillotte-Blisnick M; Huon C; Menard D; Chitnis CE
    Sci Rep; 2018 Jul; 8(1):10511. PubMed ID: 30002416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7).
    Cheng CW; Jongwutiwes S; Putaporntip C; Jackson AP
    Malar J; 2019 Jun; 18(1):197. PubMed ID: 31196098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge.
    de Camargo TM; de Freitas EO; Gimenez AM; Lima LC; de Almeida Caramico K; Françoso KS; Bruna-Romero O; Andolina C; Nosten F; Rénia L; Ertl HCJ; Nussenzweig RS; Nussenzweig V; Rodrigues MM; Reyes-Sandoval A; Soares IS
    Sci Rep; 2018 Jan; 8(1):1118. PubMed ID: 29348479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level expression of Plasmodium vivax apical membrane antigen 1 (AMA-1) in Pichia pastoris: strong immunogenicity in Macaca mulatta immunized with P. vivax AMA-1 and adjuvant SBAS2.
    Kocken CH; Dubbeld MA; Van Der Wel A; Pronk JT; Waters AP; Langermans JA; Thomas AW
    Infect Immun; 1999 Jan; 67(1):43-9. PubMed ID: 9864194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
    Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
    Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Plasmodium vivax Early Transcribed Membrane Protein 11.2 and Exported Protein 1.
    Cheng Y; Lu F; Lee SK; Kong DH; Ha KS; Wang B; Sattabongkot J; Tsuboi T; Han ET
    PLoS One; 2015; 10(5):e0127500. PubMed ID: 26011536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9.
    Rodrigues-da-Silva RN; Martins da Silva JH; Singh B; Jiang J; Meyer EV; Santos F; Banic DM; Moreno A; Galinski MR; Oliveira-Ferreira J; Lima-Junior Jda C
    PLoS One; 2016; 11(1):e0146951. PubMed ID: 26788998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population.
    Tran TM; Oliveira-Ferreira J; Moreno A; Santos F; Yazdani SS; Chitnis CE; Altman JD; Meyer EV; Barnwell JW; Galinski MR
    Am J Trop Med Hyg; 2005 Aug; 73(2):244-55. PubMed ID: 16103583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.